No segmentation disclosed for this filer. n/a
Aeolus Pharmaceuticals, Inc. booked $2.1M in FY2016 revenue, contracting 33% year over year — slower than 77% of Healthcare companies we track, at a -171.4% net margin.
No filings loaded — no CIK (non-SEC filer).